Purpose-built for targeted NGS


 

Fusions

Gene Fusions and Translocations

Gene fusions can occur as a result of chromosomal inversions, interstitial deletions, or translocations in the genome. Gene fusions can drive cancer development and progression, making them important therapeutic targets. Archer technology is purpose-built for accurate, powerful and scalable gene fusion detection with next generation sequencing.

Detected in the following assays:

Archer FusionPlex
RNA assays
CNVs

Copy number variations (CNVs)

Copy number variation (CNV) is a common form of structural genomic aberration in which large regions of the genome are deleted or duplicated. Constitutional and somatic CNVs are associated with a wide variety of cancers and represents and important area of research. Archer technology enables highly-multiplexed, quantitative assessment of genomic regions through next generation sequencing

Detected in the following assays:

Archer VariantPlex
DNA assays
Indels

Insertions/Deletions (indels)

Insertions and deletions (indels) are mutations of the genome resulting from the omission or addition of nucleotides into a sequence of DNA. Indels can alter amino acid coding sequence and cause detrimental cellular effects. Archer technology is uniquely suited for indel detection due to novel chemistry and powerful next generation sequencing analysis.

SNVs/SNPs

Single Nucleotide Variants/Polymorphisms (SNVs, SNPs)

Point mutations, single nucleotide variants (SNV) or single base substitutions of the genome can have various implications on cellular function, and can cause or lead to diseases of the genome – like cancer. Archer technology enables the precise targeting of the genome for nucleotide-level detection of point mutations with next generation sequencing.

Expression

RNA Gene Expression

Gene expression is a measure of functional RNA that can provide critical insights into cellular origin and regulation. The molecular signatures gathered from RNA abundance can assist in classification of tumor types. The quantitative nature of Archer technology allows for measuring relative RNA abundance so researchers can get more information from next generation sequencing.

Detected in the following assays:

Archer FusionPlex
RNA assays



Read the GenomeWeb article about how Anchored Multiplex PCR (AMP™) chemistry is purpose-built for CDx and IVD development

Read on GenomeWeb Now

Unrivaled cancer mutation detection by sequencing


Archer: A Culture of NGS Innovation

 

Subscribe to stay in the loop







How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2016 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.